AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
PDF (989.5 KB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Original Article | Publishing Language: Chinese

A UPLC-MS/MS method for determination of cepharanthine in rat plasma and its pharmacokinetics

Mengyan YUE1,2Mei YUAN2Aiping ZHENG2Jinjing CHE2( )Jinhua CHANG1( )
Institute of Traditional Chinese Medicine, Chengde Medical University, Hebei Provincial Key Laboratory of Traditional Chinese Medicine Research and Development, Chengde, Hebei 067000, China
Academy of Military Medical Sciences, Academy of Military Sciences, Beijing 100850, China
Show Author Information

Abstract

Objective

To establish and validate a sensitive and reliable ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) method for quantitative analysis of cepharanthine in rat plasma.

Methods

Plasma samples were treated using the protein precipitation method. Chromatographic separation was performed on column maintained at 50 ℃. Gradient elution was employed with mobile phases composed of (A) 0.05% formic acid aqueous solution containing 1 mmol/L ammonium formate and (B) 0.1% formic acid in acetonitrile at a flow rate of 0.40 mL/min. Mass spectrometric detection was carried out using an electrospray ionization (ESI) source in a positive-ion mode with multiple reaction monitoring (MRM). Mass transition m/z 607.3→576.2 was adopted for cepharanthine and m/z 260.2→ 116.1 for propranolol, the internal standard. This method was validated and used to quantify cepharanthine in plasma samples collected from rats following a single intragastric administration to investigate its pharmacokinetic profile.

Results

Cepharanthine proved to be linear in rat plasma over the concentration range of 0.1 to 80 ng/mL. The intra-and inter-batch accuracies ranged from -0.43% to 11.73%, and precisions from 3.04% to 13.83%. The recovery rates of quality control samples ranged from 86.70% to 88.48%. The accuracy and precision met the standards across six lots of the matrix. The quality control samples remained stable under the following conditions: 24 hours of storage in the autosampler at 15 ℃, followed by three freeze-thaw cycles, and 10 days of storage at -20 ℃. All these met the requirements for bioanalytical analysis of samples. Pharmacokinetic studies showed that the time to maximum concentration (Tmax) was 6 to 12 h, the maximum concentration (Cmax) was (12.31±3.78) ng/mL, the terminal elimination half-life (t1/2) was (10.07±0.66) h, and the mean residence time (MRT0-t) was (24.80±1.98) h after intragastric administration of 3 mg/kg cepharanthine to rats.

Conclusion

This study has established a UPLC-MS/MS method for quantitative analysis of cepharanthine in the rat plasma matrix, which is simple and sensitive, with a lower limit of quantification of 0.1 ng/mL.

CLC number: R285.5 Document code: A Article ID: 1674-9960(2026)04-0277-08

References

【1】
【1】
 
 
Military Medical Sciences
Pages 277-284

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Close
Close
Cite this article:
YUE M, YUAN M, ZHENG A, et al. A UPLC-MS/MS method for determination of cepharanthine in rat plasma and its pharmacokinetics. Military Medical Sciences, 2026, 50(4): 277-284. https://doi.org/10.7644/j.issn.1674-9960.2026-00007

7

Views

0

Downloads

0

Crossref

0

CSCD

Received: 13 January 2026
Published: 25 April 2026
© 2026 Military Medical Sciences